Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection

被引:2
|
作者
Duarte, R. [1 ,2 ,3 ]
Carvalho, A. [1 ,2 ]
Correia, A.
机构
[1] Ctr Diagnost Pneumol Vila Nova de Gaia, Vila Nova De Gaia, Portugal
[2] Ctr Hosp Vila Nova de Gaia Espinho, Vila Nova De Gaia, Portugal
[3] Univ Porto, Fac Med, Oporto, Portugal
关键词
Tuberculosis; Latent tuberculosis infection; Prevention; Treatment;
D O I
10.1016/j.puhe.2012.04.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:760 / 762
页数:3
相关论文
共 50 条
  • [1] Comparison of a two month regimen of pyrazinamide and rifampin with a six month regimen of isoniazide for treatment of patients with latent tuberculosis infection
    Cook, PP
    Mcneill, EL
    Allen, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1147 - 1147
  • [2] COST EFFECTIVENESS ANALYSIS TO TREAT LATENT TUBERCULOSIS INFECTION: CAMPARING ISONIAZID, RIFAMPIN AND RIFAMPIN/PYRAZINAMIDE
    Sangani, D.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A191 - A191
  • [3] Short-course isoniazid and rifampin compared with isoniazid for latent tuberculosis infection:: A randomized clinical trial
    Paloma Geijo, Maria
    Rosa Herranz, Carmen
    Vano, David
    Jesus Garcia, Angel
    Garcia, Montserrat
    Francisco Dimas, Jose
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2007, 25 (05): : 300 - 304
  • [4] The Effectiveness of a 9-Month Regimen of Isoniazid Alone versus 3-and 4-Month Regimens of Isoniazid plus Rifampin for Treatment of Latent Tuberculosis Infection in Children: Results of an 11-Year Randomized Study
    Spyridis, Nikos P. P.
    Spyridis, Panayotis G. G.
    Gelesme, Anna
    Sypsa, Vana
    Valianatou, Mina
    Metsou, Flora
    Gourgiotis, Dimitris
    Tsolia, Maria N. N.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (06) : 715 - 722
  • [5] Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains aborigines
    McNab, BD
    Marciniuk, DD
    Alvi, RA
    Tan, L
    Hoeppner, VH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) : 989 - 993
  • [6] Isoniazid vs. Rifampin for Latent Tuberculosis Infection in Jail Inmates: Toxicity and Adherence
    White, Mary C.
    Tulsky, Jacqueline P.
    Lee, Ju Ruey-Jiuan
    Chen, Lisa
    Goldenson, Joe
    Spetz, Joanne
    Kawamura, L. Masae
    [J]. JOURNAL OF CORRECTIONAL HEALTH CARE, 2012, 18 (02) : 131 - 142
  • [7] Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection
    Ijaz, Kashef
    McElroy, Peter D.
    Jereb, John
    Navin, Thomas R.
    Castro, Kenneth G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) : 464 - 465
  • [8] Tolerability and utility of two month short-course rifampin-pyrazinamide treatment of latent tuberculosis infection.
    Beeraka, P
    Oladele, A
    Blumberg, HM
    Tapia, J
    Smith, EJ
    Echols, MR
    Stringer, HG
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 170A - 170A
  • [9] Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection - Reply
    Cook, Paul P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) : 465 - 465
  • [10] Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
    Menzies, D.
    Adjobimey, M.
    Ruslami, R.
    Trajman, A.
    Sow, O.
    Kim, H.
    Baah, J. Obeng
    Marks, G. B.
    Long, R.
    Hoeppner, V.
    Elwood, K.
    Al-Jahdali, H.
    Gninafon, M.
    Apriani, L.
    Koesoemadinata, R. C.
    Kritski, A.
    Rolla, V.
    Bah, B.
    Camara, A.
    Boakye, I.
    Cook, V. J.
    Goldberg, H.
    Valiquette, C.
    Hornby, K.
    Dion, M. -J.
    Li, P. -Z.
    Hill, P. C.
    Schwartzman, K.
    Benedetti, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05): : 440 - 453